Exploration of pharmacist comfort with harm reduction behaviors: Cross-sectional latent class analysis-Reference-Cited by-同舟云学术

Exploration of pharmacist comfort with harm reduction behaviors: Cross-sectional latent class analysis

Published:2021-10 Issue: Volume: Page:
ISSN:1544-3191
Container-title:Journal of the American Pharmacists Association
language:en
Short-container-title:Journal of the American Pharmacists Association

Author:

Agley Jon^ORCID,Meyerson Beth E.,Eldridge Lori A.,Crosby Rick A.,Bentele Keith G.,Jun Mikyoung^ORCID,Vadiei Nina^ORCID,Kennedy Amy,Anderson Kirsten^ORCID

Funder

Indiana University Bloomington

Indiana University

Publisher

Elsevier BV

Subject

Pharmacology,Pharmacy,Pharmacology (nursing)

Reference43 articles.

1. During the COVID-19 pandemic, opioid overdose deaths revert to previous record levels in Ohio [published online e-pub ahead of print];Vieson;J Addict Med,2021

2. Pharmacists and the opioid crisis: a narrative review of pharmacists' practice roles;Bratberg;J Am Coll Clin Pharm,2019

3. Naloxone availability and dispensing in Indiana pharmacies 2 years after the implementation of a statewide standing order;Eldridge;J. Am. Pharm. Assoc. (2003),2020

4. A naloxone and harm reduction educational program across four years of a Doctor of pharmacy program;Maguire;Curr Pharm Teach Learn,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASAP: A pharmacy-level intervention to increase nonprescription syringe sales to reduce bloodborne illnesses;Research in Social and Administrative Pharmacy;2024-08

2. Insufficient Impact: Limited Implementation of Federal Regulatory Changes to Methadone and Buprenorphine Access in Arizona During COVID-19;AJPM Focus;2024-04

3. Implementation Documentation and Process Assessment of the PharmNet Intervention: Observational Report;JMIR Formative Research;2024-03-18

4. Come back when you’re infected: pharmacy access to sterile syringes in an Arizona Secret Shopper Study, 2023;Harm Reduction Journal;2024-02-22

5. Implementation Documentation and Process Assessment of the PharmNet Intervention: Observational Report (Preprint);2023-10-28